These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21075542)

  • 21. Aerobic capacity, oxidant stress, and chronic obstructive pulmonary disease--a new take on an old hypothesis.
    Stevenson CS; Koch LG; Britton SL
    Pharmacol Ther; 2006 Apr; 110(1):71-82. PubMed ID: 16343638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oxidative stress in pathogenesis of COPD].
    Betsuyaku T
    Nihon Rinsho; 2007 Apr; 65(4):633-6. PubMed ID: 17419380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New concepts in the pathogenesis and pathophysiology of COPD].
    Fira-Mladinescu O; Tudorache V; Mihăicută S; Muntean D
    Pneumologia; 2007; 56(1):24, 26-31. PubMed ID: 17491205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of COPD. Part III. Inflammation in COPD.
    Roth M
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):375-80. PubMed ID: 18371261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomere shortening in chronic obstructive pulmonary disease.
    Houben JM; Mercken EM; Ketelslegers HB; Bast A; Wouters EF; Hageman GJ; Schols AM
    Respir Med; 2009 Feb; 103(2):230-6. PubMed ID: 18945604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases.
    Kinnula VL
    Thorax; 2005 Aug; 60(8):693-700. PubMed ID: 16061713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease.
    To Y; Ito K; Kizawa Y; Failla M; Ito M; Kusama T; Elliott WM; Hogg JC; Adcock IM; Barnes PJ
    Am J Respir Crit Care Med; 2010 Oct; 182(7):897-904. PubMed ID: 20224070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic obstructive pulmonary disease and genetics].
    Ingebrigtsen T; Thomsen SF; Vestbo J; Backer V
    Ugeskr Laeger; 2008 Sep; 170(38):2971-3. PubMed ID: 18808751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of chronic obstructive pulmonary disease.
    Rennard SI
    Pneumonol Alergol Pol; 2011; 79(2):132-8. PubMed ID: 21351065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
    Xu L; Cai BQ; Zhu YJ
    Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise-induced systemic effects in muscle-wasted patients with COPD.
    Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
    Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.
    Yoshida T; Tuder RM
    Physiol Rev; 2007 Jul; 87(3):1047-82. PubMed ID: 17615396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.
    Barnes PJ; Ito K; Adcock IM
    Lancet; 2004 Feb; 363(9410):731-3. PubMed ID: 15001333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The habit of smoking--a sure step towards COPD].
    Trofor A; Frăsilă EI
    Pneumologia; 2007; 56(2):85-90. PubMed ID: 18019753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance.
    Mak JC
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):368-74. PubMed ID: 18371260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malondialdehyde and superoxide dismutase correlate with FEV(1) in patients with COPD associated with wood smoke exposure and tobacco smoking.
    Montaño M; Cisneros J; Ramírez-Venegas A; Pedraza-Chaverri J; Mercado D; Ramos C; Sansores RH
    Inhal Toxicol; 2010 Aug; 22(10):868-74. PubMed ID: 20583895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation and infection in exacerbations of chronic obstructive pulmonary disease.
    Pietila MP; Thomas CF
    Semin Respir Infect; 2003 Mar; 18(1):9-16. PubMed ID: 12652449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary modulation of oxidative stress in chronic obstructive pulmonary disease patients.
    de Batlle J; Barreiro E; Romieu I; Mendez M; Gómez FP; Balcells E; Ferrer J; Orozco-Levi M; Gea J; Antó JM; Garcia-Aymerich J
    Free Radic Res; 2010 Nov; 44(11):1296-303. PubMed ID: 20815775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oxidatif-stress and COPD. Role of infection. Prevention].
    Léophonte P; Guérin JC; Lebas FX; Liard F; Boulanger P
    Med Mal Infect; 2006 May; 36(5):245-52. PubMed ID: 16584860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma.
    Sutherland ER; Martin RJ
    J Allergy Clin Immunol; 2003 Nov; 112(5):819-27; quiz 828. PubMed ID: 14610463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.